Abstract
A sensitive method for the determination of a new cephalosporin in human serum and urine is described. The sensitivity of the procedure is derived from a high-performance liquid chromatographic separation which utilizes the different selectivities of two columns. Partial separation of the agent from deproteinized serum or diluted urine is achieved by an anion-exchange column. To concentrate the large volume of the eluent fraction containing the compound from the anion-exchange column, a reversed-phase short column is placed between the anion-exchange column and a reversed-phase analytical column. The separation is completed by switching the eluent fraction containing the compound from the second column to the analytical column. The compound is detected by ultraviolet absorption at 295 nm. Quantitation is possible down to 0.05 μg/ml using 300 μl of serum and down to 0.5 μg/ml using 50 μl of urine. The coefficients of variation of the method are 6.8% and 0.6% in serum when spiked at the 0.05 μg/ml and 1.0 μg/ml level, respectively. One assay can be completed in 16 min. Serum levels and urinary excretion data obtained with this method are given for three healthy volunteers who had received a 100-mg oral dose of the compound.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Chromatography B: Biomedical Sciences and Applications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
